Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioSyent Inc. Proxy Solicitation & Information Statement 2019

May 1, 2019

43507_rns_2019-05-01_35472b43-24b9-41fe-bc28-6e3692aec24c.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

BIOSYENT INC.

NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS

NOTICE is hereby given that the annual general and special meeting of shareholders of BioSyent Inc. (the “Company”) will be held at the Toronto Airport Marriott Hotel in the Forum Room 3 at 901 Dixon Road, Toronto, Ontario M9W 1J5 on May 28, 2019 at 9:00 a.m. (Eastern Time) for the following purposes:

  1. To receive the audited consolidated financial statements for the fiscal year ended December 31, 2018, together with the independent auditor's report thereon.

  2. To elect directors for the ensuing year.

  3. To appoint auditors for the ensuing year and to authorize the directors to fix the remuneration to be paid to the auditors.

  4. To re-approve the Company’s “10% rolling” incentive stock option plan in the form attached as Schedule “B” to the accompanying information circular.

  5. To transact such other business as may properly be transacted at such meeting or at any adjournment thereof.

If you are unable to attend the annual general meeting in person, please read the information regarding proxies contained in the accompanying information circular and the notes included with the accompanying instrument of proxy and then complete and return the proxy within the indicated time. It should be noted that the enclosed proxy is solicited by management of the Company, but you may amend it, if you so desire, by striking out the names listed therein and inserting in the space provided the name of the person you wish to represent you at the meeting.

DATED at Toronto, Ontario, this 15th day of April, 2019

BY ORDER OF THE BOARD

René C. Goehrum Chairman and Chief Executive Officer